Rezolute (RZLT) Cash from Financing Activities (2010 - 2026)
Rezolute recorded quarterly Cash from Financing Activities of $747000.0 in Q1 2026, up 109.83% quarter-over-quarter from $356000.0 in Q4 2025, and up 7370.0% year-over-year from $10000.0 in Q1 2025.
Rezolute's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $747000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 7370.0% year-over-year to $747000.0; the TTM figure through Mar 2026 stood at $103.2 million (up 48.47% YoY), while the FY2025 annual figure was $107.3 million, up 70.28% from the prior year.
- Cash from Financing Activities came in at $747000.0 for Q1 2026 at Rezolute, up from $356000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $101.2 million in Q2 2025 to a low of -$19000.0 in Q1 2022.
- A 4-year average of $23.2 million and a median of $829000.0 in 2025 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities plunged 83.44% in 2025 and soared 7370.0% in 2026, its largest moves.
- Rezolute's Cash from Financing Activities stood at $11.6 million in 2022, then tumbled by 94.32% to $657000.0 in 2024, then sank by 45.81% to $356000.0 in 2025, then surged by 109.83% to $747000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $747000.0, $356000.0, and $911000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | 747,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 747,000.00 |
| Mar 31, 2026 | 747,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Jun 30, 2025 | 101.16 Mn |
| Jun 30, 2025 | 101.16 Mn |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 657,000.00 |
| Dec 31, 2024 | 657,000.00 |
| Sep 30, 2024 | 5.50 Mn |
| Sep 30, 2024 | 5.50 Mn |
| Jun 30, 2024 | 63.33 Mn |
| Jun 30, 2024 | 63.33 Mn |
| Mar 31, 2024 | -3,000.00 |
| Mar 31, 2024 | -3,000.00 |
| Sep 30, 2022 | 11.57 Mn |
| Sep 30, 2022 | 11.57 Mn |
| Jun 30, 2022 | 94.10 Mn |
| Jun 30, 2022 | 94.10 Mn |
| Mar 31, 2022 | -19,000.00 |
| Mar 31, 2022 | -19,000.00 |
| Dec 31, 2021 | 52.31 Mn |
| Dec 31, 2021 | 52.31 Mn |
| Sep 30, 2021 | 2.59 Mn |
| Sep 30, 2021 | 2.59 Mn |
| Jun 30, 2021 | 14.29 Mn |
| Jun 30, 2021 | 14.29 Mn |
| Mar 31, 2021 | -214,000.00 |
| Mar 31, 2021 | -214,000.00 |
| Dec 31, 2020 | 37.46 Mn |
| Dec 31, 2020 | 37.46 Mn |
| Dec 31, 2019 | -21,000.00 |
| Dec 31, 2019 | -21,000.00 |
| Sep 30, 2019 | 22.57 Mn |
| Sep 30, 2019 | 22.57 Mn |
| Mar 31, 2019 | 23.50 Mn |
| Mar 31, 2019 | 23.50 Mn |
| Dec 31, 2018 | 1.50 Mn |
| Dec 31, 2018 | 1.50 Mn |
| Jun 30, 2018 | 3.90 Mn |
| Jun 30, 2018 | 3.90 Mn |
| Mar 31, 2018 | 1.20 Mn |
| Mar 31, 2018 | 1.20 Mn |
| Sep 30, 2017 | 4.44 Mn |
| Sep 30, 2017 | 4.44 Mn |
| Jun 30, 2017 | 3.78 Mn |
| Jun 30, 2017 | 3.78 Mn |
| Mar 31, 2017 | 4.50 Mn |
| Mar 31, 2017 | 4.50 Mn |
| Dec 31, 2016 | 3.32 Mn |
| Dec 31, 2016 | 3.32 Mn |
| Sep 30, 2016 | 2.33 Mn |
| Sep 30, 2016 | 2.33 Mn |
| Jun 30, 2016 | 5.79 Mn |
| Jun 30, 2016 | 5.79 Mn |
| Mar 31, 2016 | 3.09 Mn |
| Mar 31, 2016 | 3.09 Mn |
| Dec 31, 2015 | 1.87 Mn |
| Dec 31, 2015 | 1.87 Mn |
| Sep 30, 2015 | -23,109.00 |
| Sep 30, 2015 | -23,109.00 |
| Jun 30, 2015 | 1.25 Mn |
| Jun 30, 2015 | 1.25 Mn |
| Mar 31, 2015 | 2.60 Mn |
| Mar 31, 2015 | 2.60 Mn |
| Dec 31, 2014 | 6.18 Mn |
| Dec 31, 2014 | 6.18 Mn |
| Jun 30, 2014 | 3.21 Mn |
| Jun 30, 2014 | 3.21 Mn |
| Mar 31, 2014 | 5.21 Mn |
| Mar 31, 2014 | 5.21 Mn |
| Dec 31, 2013 | 1.51 Mn |
| Dec 31, 2013 | 1.51 Mn |
| Jun 30, 2013 | -157,500.00 |
| Jun 30, 2013 | -157,500.00 |
| Mar 31, 2013 | 270,000.00 |
| Mar 31, 2013 | 270,000.00 |
| Dec 31, 2012 | 630,000.00 |
| Dec 31, 2012 | 630,000.00 |
| Sep 30, 2012 | 675,000.00 |
| Sep 30, 2012 | 675,000.00 |
| Jun 30, 2012 | 760,500.00 |
| Jun 30, 2012 | 760,500.00 |
| Mar 31, 2012 | 1.16 Mn |
| Mar 31, 2012 | 1.16 Mn |
| Dec 31, 2011 | 735,700.00 |
| Dec 31, 2011 | 735,700.00 |
| Sep 30, 2011 | 41,800.00 |
| Sep 30, 2011 | 41,800.00 |
| Dec 31, 2010 | 13,800.00 |
| Dec 31, 2010 | 13,800.00 |
| Sep 30, 2010 | 28,000.00 |
| Sep 30, 2010 | 28,000.00 |